NCT07152873View on ClinicalTrials.gov

A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

October 20, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions

Mixed Dyslipidemia

Interventions

DRUG

AD-117

AD-117 1Tab., Per Oral

DRUG

AD-117A

AD-117A 1Tab., Per Oral

Trial Locations (1)

Unknown

H Plus Yangji Hospital, Seoul

All Listed Sponsors

lead

Addpharma Inc.

INDUSTRY